Amneal Pharmaceuticals Inc (2DT.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
As of 08:06AM CEST. Market open.
| Previous close | 6.30 |
| Open | 6.30 |
| Bid | 6.15 x N/A |
| Ask | 6.20 x N/A |
| Day's range | 6.30 - 6.30 |
| 52-week range | 2.08 - 6.30 |
| Volume | |
| Avg. volume | 38 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 29 Feb 2024 - 04 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Amneal Pharmaceuticals First Quarter 2024 Earnings: US$0.30 loss per share (vs US$0.046 loss in 1Q 2023)
Amneal Pharmaceuticals ( NASDAQ:AMRX ) First Quarter 2024 Results Key Financial Results Revenue: US$659.2m (up 18% from...
- GuruFocus.com
Amneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
Amneal Pharmaceuticals reports significant revenue and EBITDA growth in Q1 2024, driven by new product launches and strong market performance.
Business WireAmneal Reports First Quarter 2024 Financial Results
BRIDGEWATER, N.J., May 03, 2024--AMNEAL REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
© 2024 Yahoo. All rights reserved.